Follow The Filings

NRXS Neuraxis

Neuraxis earnings company data as of 4:47 AM ET 10/24

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by NRXS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NRXS insider trades
  • $1.4M bought by 5 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Brian Allen Carrico CEO
    Buy
    $1,297 268 shares at $4.84 +0.1% to stake
    Traded Oct 8 Filed Oct 8
  2. Thomas Joeseph Carrico CRO, CCO, CPO
    Buy
    $1,588 328 shares at $4.84 +0.2% to stake
    Traded Oct 8 Filed Oct 8
  3. Timothy Robert Henrichs CFO
    Buy
    $9,375 1,937 shares at $4.84 +26% to stake
    Traded Oct 8 Filed Oct 8
  4. Timothy Robert Henrichs CFO
    Buy
    $15K 7,593 shares at $1.96 New stake
    Traded Apr 1 Filed Apr 3
  5. Thomas Joeseph Carrico CRO, CCO, CPO
    Buy
    $1,307 667 shares at $1.96 +0.2% to stake
    Traded Apr 1 Filed Apr 3
  6. Brian Allen Carrico CEO
    Buy
    $16K 8,060 shares at $1.96 +2.4% to stake
    Traded Apr 1 Filed Apr 3
  7. Brian Hannasch 10% owner
    Buy
    $383K 80,000 shares at $4.79 +7.1% to stake
    Traded Feb 11–12 Filed Feb 13
  8. Gil Aharon Director
    Buy
    $1M 286,138 shares at $3.52 New stake
    Traded Dec 23, 2025 Filed Dec 29, 2025

Also filed in the last 12 months, not counted as buying or selling: 15 stock grants.

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
8-K 8.01
8-K 5.02,8.01
10-Q
424B3
SCHEDULE 13G/A —
8-K 8.01
8-K 5.07
10-Q
SCHEDULE 13G/A —
DEF 14A
DEFA14A
8-K 8.01,9.01
424B5
8-K 2.02
10-K

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.